616 related articles for article (PubMed ID: 29606314)
1. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
2. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
[TBL] [Abstract][Full Text] [Related]
3. Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Zhang SX; Liu L; Zhao W
Trends Cancer; 2018 Apr; 4(4):268-271. PubMed ID: 29606309
[TBL] [Abstract][Full Text] [Related]
4. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
5. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
7. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Zhang Y; Ho SH; Li B; Nie G; Li S
Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
[TBL] [Abstract][Full Text] [Related]
8. Transport Barriers and Oncophysics in Cancer Treatment.
Nizzero S; Ziemys A; Ferrari M
Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
Jia M; Zhang D; Zhang C; Li C
J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
[TBL] [Abstract][Full Text] [Related]
10. Barriers to drug delivery in interventional oncology.
Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
[TBL] [Abstract][Full Text] [Related]
11. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.
Jain RK
J Clin Oncol; 2013 Jun; 31(17):2205-18. PubMed ID: 23669226
[TBL] [Abstract][Full Text] [Related]
12. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
Singh A; Brito I; Lammerding J
Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
14. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
15. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine.
Tian Y; Cheng T; Sun F; Zhou Y; Yuan C; Guo Z; Wang Z
Adv Colloid Interface Sci; 2024 Apr; 326():103124. PubMed ID: 38461766
[TBL] [Abstract][Full Text] [Related]
16. Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination.
Varol C; Sagi I
FEBS J; 2018 Feb; 285(4):734-751. PubMed ID: 29106767
[TBL] [Abstract][Full Text] [Related]
17. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
Fang H; Declerck YA
Cancer Res; 2013 Aug; 73(16):4965-77. PubMed ID: 23913938
[TBL] [Abstract][Full Text] [Related]
18. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
19. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.
Martin JD; Fukumura D; Duda DG; Boucher Y; Jain RK
Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663981
[TBL] [Abstract][Full Text] [Related]
20. Engineering extracellular matrix to improve drug delivery for cancer therapy.
He X; Yang Y; Li L; Zhang P; Guo H; Liu N; Yang X; Xu F
Drug Discov Today; 2020 Sep; 25(9):1727-1734. PubMed ID: 32629171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
